58 related articles for article (PubMed ID: 21947696)
1. Prognosis of esophageal squamous cell carcinoma in patients positive for human epidermal growth factor receptor family can be improved by initial chemotherapy with docetaxel, fluorouracil, and cisplatin.
Yamamoto Y; Yamai H; Seike J; Yoshida T; Takechi H; Furukita Y; Kajiura K; Minato T; Bando Y; Tangoku A
Ann Surg Oncol; 2012 Mar; 19(3):757-65. PubMed ID: 21947696
[TBL] [Abstract][Full Text] [Related]
2. Small interfering RNA targeting epidermal growth factor receptor enhances chemosensitivity to cisplatin, 5-fluorouracil and docetaxel in head and neck squamous cell carcinoma.
Nozawa H; Tadakuma T; Ono T; Sato M; Hiroi S; Masumoto K; Sato Y
Cancer Sci; 2006 Oct; 97(10):1115-24. PubMed ID: 16984384
[TBL] [Abstract][Full Text] [Related]
3. A randomized phase II efficacy and correlative studies of cetuximab with or without sorafenib in recurrent and/or metastatic head and neck squamous cell carcinoma.
Gilbert J; Schell MJ; Zhao X; Murphy B; Tanvetyanon T; Leon ME; Neil Hayes D; Haigentz M; Saba N; Nieva J; Bishop J; Sidransky D; Ravi R; Bedi A; Chung CH
Oral Oncol; 2015 Apr; 51(4):376-82. PubMed ID: 25593015
[TBL] [Abstract][Full Text] [Related]
4. Expression status of p53 and organic cation transporter 1 is correlated with poor response to preoperative chemotherapy in esophageal squamous cell carcinoma.
Izutsu M; Domoto T; Kamoshida S; Ohsaki H; Matsuoka H; Umeki Y; Shiogama K; Hirayama M; Suda K; Uyama I
World J Surg Oncol; 2022 Apr; 20(1):105. PubMed ID: 35365176
[TBL] [Abstract][Full Text] [Related]
5. Itraconazole Exerts Its Antitumor Effect in Esophageal Cancer By Suppressing the HER2/AKT Signaling Pathway.
Zhang W; Bhagwath AS; Ramzan Z; Williams TA; Subramaniyan I; Edpuganti V; Kallem RR; Dunbar KB; Ding P; Gong K; Geurkink SA; Beg MS; Kim J; Zhang Q; Habib AA; Choi SH; Lapsiwala R; Bhagwath G; Dowell JE; Melton SD; Jie C; Putnam WC; Pham TH; Wang DH
Mol Cancer Ther; 2021 Oct; 20(10):1904-1915. PubMed ID: 34376577
[TBL] [Abstract][Full Text] [Related]
6. CAN017, a novel anti-HER3 antibody, exerted great potency in mouse avatars of esophageal squamous cell carcinoma with NRG1 as a biomarker.
Liao H; Zhang C; Chen Z; Gao Y; Li Z; Wang L; Li Y; Shen L; Gao J
Am J Cancer Res; 2021; 11(4):1697-1708. PubMed ID: 33948383
[TBL] [Abstract][Full Text] [Related]
7. The genetic effect and molecular function of the SOCS5 in the prognosis of esophageal squamous cell carcinoma.
Yang PW; Chang YH; Wong LF; Lin CC; Huang PM; Hsieh MS; Lee JM
J Cancer; 2021; 12(8):2216-2229. PubMed ID: 33758600
[TBL] [Abstract][Full Text] [Related]
8. A new model system identifies epidermal growth factor receptor-human epidermal growth factor receptor 2 (HER2) and HER2-human epidermal growth factor receptor 3 heterodimers as potent inducers of oesophageal epithelial cell invasion.
Fichter CD; Przypadlo CM; Buck A; Herbener N; Riedel B; Schäfer L; Nakagawa H; Walch A; Reinheckel T; Werner M; Lassmann S
J Pathol; 2017 Dec; 243(4):481-495. PubMed ID: 28940194
[TBL] [Abstract][Full Text] [Related]
9. Knockdown of Ubiquitin-Specific Protease 14 (USP14) Inhibits the Proliferation and Tumorigenesis in Esophageal Squamous Cell Carcinoma Cells.
Zhang J; Zhang D; Sun L
Oncol Res; 2017 Jan; 25(2):249-257. PubMed ID: 27629392
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact and potential interaction of EGFR and c-Met in the progression of esophageal squamous cell carcinoma.
Wang H; Jiang D; Song Q; Xu C; Shi Y; Li X; Huang J; Xu Y; Sujie A; Zeng H; Zhong Y; Tan L; Hou Y
Tumour Biol; 2016 Jul; 37(7):9771-9. PubMed ID: 26810066
[TBL] [Abstract][Full Text] [Related]
11. High-dose nimotuzumab improves the survival rate of esophageal cancer patients who underwent radiotherapy.
Wang C; Fu X; Cai X; Wu X; Hu X; Fan M; Xiang J; Zhang Y; Chen H; Jiang G; Zhao K
Onco Targets Ther; 2016; 9():117-22. PubMed ID: 26766917
[TBL] [Abstract][Full Text] [Related]
12. Right versus left transthoracic approach for lymph node-negative esophageal squamous cell carcinoma.
Ma Q; Liu W; Long H; Rong T; Zhang L; Lin Y; Ma G
J Cardiothorac Surg; 2015 Sep; 10():123. PubMed ID: 26384482
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylated AKT1 is associated with poor prognosis in esophageal squamous cell carcinoma.
Zhu Z; Yu W; Fu X; Sun M; Wei Q; Li D; Chen H; Xiang J; Li H; Zhang Y; Zhao W; Zhao K
J Exp Clin Cancer Res; 2015 Sep; 34(1):95. PubMed ID: 26338103
[TBL] [Abstract][Full Text] [Related]
14. High EGFR and low p-Akt expression is associated with better outcome after nimotuzumab-containing treatment in esophageal cancer patients: preliminary clinical result and testable hypothesis.
Wang CY; Deng JY; Cai XW; Fu XL; Li Y; Zhou XY; Wu XH; Hu XC; Fan M; Xiang JQ; Zhang YW; Chen HQ; Perez R; Jiang GL; Zhao KL
Oncotarget; 2015 Jul; 6(21):18674-82. PubMed ID: 26124180
[TBL] [Abstract][Full Text] [Related]
15. Current status of predictive biomarkers for neoadjuvant therapy in esophageal cancer.
Uemura N; Kondo T
World J Gastrointest Pathophysiol; 2014 Aug; 5(3):322-34. PubMed ID: 25133032
[TBL] [Abstract][Full Text] [Related]
16. ErbB targeting inhibitors repress cell migration of esophageal squamous cell carcinoma and adenocarcinoma cells by distinct signaling pathways.
Fichter CD; Gudernatsch V; Przypadlo CM; Follo M; Schmidt G; Werner M; Lassmann S
J Mol Med (Berl); 2014 Nov; 92(11):1209-23. PubMed ID: 25091467
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of epidermal growth factor receptor in locally advanced esophageal squamous cell carcinoma for patients receiving chemoradiotherapy.
Gao Z; Meng X; Mu D; Sun X; Yu J
Oncol Lett; 2014 Apr; 7(4):1118-1122. PubMed ID: 24944678
[TBL] [Abstract][Full Text] [Related]
18. RNA-seq reveals determinants of sensitivity to chemotherapy drugs in esophageal carcinoma cells.
Yang LX; Li BL; Liu XH; Yuan Y; Lu CJ; Chen R; Zhao J
Int J Clin Exp Pathol; 2014; 7(4):1524-33. PubMed ID: 24817948
[TBL] [Abstract][Full Text] [Related]
19. HER2 status in Barrett's esophagus & esophageal cancer: a meta analysis.
Gowryshankar A; Nagaraja V; Eslick GD
J Gastrointest Oncol; 2014 Feb; 5(1):25-35. PubMed ID: 24490040
[TBL] [Abstract][Full Text] [Related]
20. miR-302b is a potential molecular marker of esophageal squamous cell carcinoma and functions as a tumor suppressor by targeting ErbB4.
Zhang M; Yang Q; Zhang L; Zhou S; Ye W; Yao Q; Li Z; Huang C; Wen Q; Wang J
J Exp Clin Cancer Res; 2014 Jan; 33(1):10. PubMed ID: 24438167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
